GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » IMAC Holdings Inc (NAS:BACK) » Definitions » Debt-to-EBITDA

BACK (IMAC Holdings) Debt-to-EBITDA : 0.00 (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is IMAC Holdings Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

IMAC Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.00 Mil. IMAC Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.00 Mil. IMAC Holdings's annualized EBITDA for the quarter that ended in Mar. 2024 was $-1.63 Mil. IMAC Holdings's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for IMAC Holdings's Debt-to-EBITDA or its related term are showing as below:

BACK' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -2.81   Med: -1.26   Max: -0.39
Current: -0.39

During the past 8 years, the highest Debt-to-EBITDA Ratio of IMAC Holdings was -0.39. The lowest was -2.81. And the median was -1.26.

BACK's Debt-to-EBITDA is ranked worse than
100% of 445 companies
in the Healthcare Providers & Services industry
Industry Median: 2.45 vs BACK: -0.39

IMAC Holdings Debt-to-EBITDA Historical Data

The historical data trend for IMAC Holdings's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMAC Holdings Debt-to-EBITDA Chart

IMAC Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial -1.86 -2.81 -0.70 -0.41 -

IMAC Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.54 -0.41 -0.10 - -

Competitive Comparison of IMAC Holdings's Debt-to-EBITDA

For the Medical Care Facilities subindustry, IMAC Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IMAC Holdings's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, IMAC Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where IMAC Holdings's Debt-to-EBITDA falls into.



IMAC Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

IMAC Holdings's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / -5.947
=0.00

IMAC Holdings's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / -1.632
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


IMAC Holdings  (NAS:BACK) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


IMAC Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of IMAC Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


IMAC Holdings Business Description

Traded in Other Exchanges
N/A
Address
3401 Mallory Lane, Suite 100, Franklin, TN, USA, 37067
IMAC Holdings Inc is a provider and manager of value-based, conservative medical care combining life science advancements with traditional medical care for movement-restricting diseases and conditions in IMAC Regeneration Centers and BackSpace clinics. Its Innovative Medical Advancements and Care (IMAC) Regeneration Centers combine medical and physical procedures to improve patient experiences and outcomes and reduce healthcare costs as compared to other available treatment options.
Executives
Benjamin S Lerner officer: Chief Operating Officer C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
Matthew C Wallis director, 10 percent owner, officer: Chief Operating Officer C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
Michael D Pruitt director 11220 ELM LANE, SUITE 203, CHARLOTTE NC 28277
Cary Sucoff director 1612 EAST CAPE CORAL PKWY, C/O LEGACY EDUCATION ALLIANCE, INC., CAPE CORAL FL 33904
Maurice E. Evans director C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
Jeffrey S Ervin director, officer: Chief Executive Officer C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
Hayden Gerard M Jr director C/O PRIVATE BUSINESS INC, P O BOX 1603, BRENTWOOD TN 37024
David Ellwanger director C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
Sheri Gardzina officer: Interim CFO C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
George P Hampton director C/O HORIZON PHARMA PLC, 520 LAKE COOK ROAD, STE 520, DEERFIELD IL 60015
Dean Weiland director C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
Dwight Anthony Bond officer: Chief Financial Officer C/O IMAC HOLDINGS, INC., BRENTWOOD TN 37027